首页> 外文学位 >A novel multi-step approach using humanized HLA-DR4 transgenic mice and bioinformatics to identify T-cell reactive antigens against Francisella tularensis.
【24h】

A novel multi-step approach using humanized HLA-DR4 transgenic mice and bioinformatics to identify T-cell reactive antigens against Francisella tularensis.

机译:一种新颖的多步骤方法,使用人源化HLA-DR4转基因小鼠和生物信息学来鉴定针对土拉弗朗西斯菌的T细胞反应性抗原。

获取原文
获取原文并翻译 | 示例

摘要

Francisella tularensis is a Gram negative facultative intracellular bacterium that causes tularemia in humans. There is no licensed vaccine available against this disease. Membrane proteins have been evaluated as vaccine candidates in many bacterial pathogens because of their important roles in initial infection, intracellular survival, virulence and immune evasion. Control of F. tularensis infection is mostly dependent on cell-mediated immune responses, however, recent studies have shown that humoral immunity also plays an important role. A novel approach has been developed in this study to identify putative T-cell reactive antigens using humanized mice along with bioinformatics tools. Membrane proteins of F. tularensis subsp. novicida were extracted by a non-ionic detergent Triton X-114 and fractionated using liquid-phase isoelectric focusing and whole gel elution. A total of 83 proteins were identified from fractions that induced strong cell-mediated immune responses. Using bioinformatics algorithms, such as PSLpred, BLASTP, and HLA-DR4Pred, allowed the identification of eight antigens that are membrane or periplasmic proteins, with low homology to human and mouse proteins, and contain putative HLA-DR4 MHC class II binding epitopes. Recall assays measuring cellular cytokine production in F. tularensis subsp. novicida Deltaiglc immunized HLA-DR4 transgenic mice confirmed that one of the identified proteins, FopB is a T-cell antigen. Moreover, FopB has been shown to react with human convalescent tularemia sera and is homologous to an outer membrane protein of Coxiella. These observations further validated our immunological and bioinformatics screening methods. The approach described in this study provides a useful tool to identify potential vaccine candidates against tularemia with high relevance to humans.
机译:图拉弗朗西斯菌是一种革兰氏阴性兼性细胞内细菌,可导致人类Tularemia。没有针对这种疾病的许可疫苗。由于膜蛋白在初始感染,细胞内存活,毒力和免疫逃逸中起重要作用,因此已被评估为许多细菌病原体的候选疫苗。控制土拉弗朗西斯菌的感染主要取决于细胞介导的免疫反应,但是,最近的研究表明,体液免疫也起着重要的作用。在这项研究中已经开发出一种新颖的方法来使用人源化小鼠以及生物信息学工具鉴定推定的T细胞反应性抗原。 Tularensis亚种的膜蛋白用非离子去污剂Triton X-114提取夜蛾科病毒,并用液相等电聚焦和全凝胶洗脱法分离。从诱导强细胞介导的免疫反应的级分中鉴定出总共83种蛋白质。使用生物信息学算法,例如PSLpred,BLASTP和HLA-DR4Pred,可以鉴定八种抗原,它们是膜或周质蛋白,与人和小鼠蛋白的同源性低,并包含推定的HLA-DR4 MHC II类结合表位。召回分析,用于测量土拉弗朗西斯菌亚种中细胞因子的产生。 Novicida Deltaiglc免疫的HLA-DR4转基因小鼠证实,已鉴定的蛋白质之一FopB是T细胞抗原。而且,已经显示出FopB与人恢复期tularemia血清反应,并且与Coxiella的外膜蛋白同源。这些观察结果进一步验证了我们的免疫学和生物信息学筛选方法。这项研究中描述的方法提供了一种有用的工具,可用于识别潜在的针对人类的Tularemia候选疫苗。

著录项

  • 作者

    Goluguri, Tata Reddy.;

  • 作者单位

    The University of Texas at San Antonio.;

  • 授予单位 The University of Texas at San Antonio.;
  • 学科 Microbiology.;Bioinformatics.;Immunology.;Molecular biology.
  • 学位 M.S.
  • 年度 2008
  • 页码 58 p.
  • 总页数 58
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 11:38:57

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号